Professor of Medicine; Director, Adult Sickle Cell Disease Program; Clinical Director, Adult Stem CVanderbilt UniversityNashville, Tennessee
Great
Disclosure information not submitted.
AM25-ST-14-L - Allogeneic Transplant, Gene Therapy, or the Evolving Drug Landscape in Sickle Cell Disease: Helping Patients Choose Between Options
Saturday, October 25, 202510:45 AM - 12:15 PM PT